Showing results (131-140 of 571) with videos related to
Sort By:
Pageof 58
European Heart Journal. Cardiovascular Pharmacotherapy|January 10, 2024
Pharmacological and clinical appraisal of factor XI inhibitor drugsGiovanni Occhipinti, Claudio Laudani, Marco Spagnolo, et al.Journal of the American College of Cardiology|October 4, 2023
Antithrombotic Therapy for Primary and Secondary Prevention of Ischemic Stroke: JACC State-of-the-Art ReviewAntonio Greco, Giovanni Occhipinti, Daniele Giacoppo, et al.Expert Review of Cardiovascular Therapy|June 15, 2019
Antithrombotic pharmacotherapy after transcatheter aortic valve implantation: an updateAntonio Greco, Piera Capranzano, Marco Barbanti, et al.Reviews in Cardiovascular Medicine|July 30, 2024
P2Y12 Inhibitor Monotherapy: Considerations for Acute and Long-Term Secondary Prevention Post-PCIAntonio Greco, Maria Sara Mauro, Davide Capodanno, et al.European Heart Journal. Cardiovascular Pharmacotherapy|May 8, 2020
Choices in antithrombotic management for patients with atrial fibrillation undergoing percutaneous coronary intervention: questions (and answers) in chronological sequenceAndrea Rubboli, Marco Valgimigli, Davide Capodanno, et al.Expert Opinion on Investigational Drugs|November 1, 2018
CSL112, a reconstituted, infusible, plasma-derived apolipoprotein A-I: safety and tolerability profiles and implications for management in patients with myocardial infarctionDavide Capodanno, Roxana Mehran, C Michael Gibson, et al.Expert Review of Cardiovascular Therapy|September 16, 2014
Updates on NSAIDs in patients with and without coronary artery disease: pitfalls, interactions and cardiovascular outcomesGiuseppe Gargiulo, Davide Capodanno, Giovanni Longo, et al.Revista Espanola De Cardiologia (English Ed.)|February 21, 2023
Diuresis-matched versus standard hydration in patients undergoing percutaneous cardiovascular procedures: meta-analysis of randomized clinical trialsGiovanni Occhipinti, Claudio Laudani, Marco Spagnolo, et al.European Heart Journal. Case Reports|November 12, 2024
A rare complication of blood culture-negative infective endocarditis on tricuspid valve: case reportGiovanni Bellina, Salvatore Scandura, Salvatore Lentini, et al.American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 1, 2024
Characteristics and Impact of Randomized Trials on Drugs or Devices in Cardiovascular MedicineMarco Spagnolo, Claudio Laudani, Antonio Greco, et al.Pageof 58